- $88.09m
- $74.94m
- $0.54m
Brief: Mainz Biomed BV Files For Firm Commitment Public Offering Of 1.5 Million Ordinary Shares Of Mainz Biomed N.V. - SEC Filing
U.S. STOCKS ON THE MOVE-Salesforce, Mainz Biomed
U.S. STOCKS ON THE MOVE-Wells Fargo, Salesforce, Sony
Mainz Biomed nearly doubles on mRNA biomarkers deal
Brief: Mainz Biomed Acquires Exclusive Rights To Novel mRNA Biomarkers For Integration Into ColoAlert
Brief: Mainz Biomed Expands Coloalert Commercialization With Ganzimmun Diagnostics In Europe
Brief: Mainz Biomed Launches Ecommerce Store For Coloalert To Assist Patient Access During Covid-19 Pandemic
Brief: Mainz Biomed Establishes Partnership With Precision For Medicine To Support ColoAlert's U.S. Regulatory And Commercial Strategy
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
Brief: Mainz Biomed N.V. Announces Pricing Of Initial Public Offering
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:55 AM
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:51 AM
NASDAQ RESUMED AT 09:51 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:49 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:42 AM
NASDAQ RESUMED AT 09:41 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:40 AM
NASDAQ RESUMED AT 09:40 AM